These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1219674)

  • 1. 780SE in the management of disorders of lipid and glucose metabolism.
    Riveline B
    Postgrad Med J; 1975; 51 Suppl 1():162-4. PubMed ID: 1219674
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological effects of 780SE (992) on hyperlipidaemic and obese rats.
    Duhault J; Boulander M; Beregi L
    Postgrad Med J; 1975; 51 Suppl 1():99-104. PubMed ID: 1219688
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the effects of 780SE on carbohydrate tolerance and plasma hormone and lipid profile in maturity-onset diabetes.
    Asmal AC; Leary WP
    Postgrad Med J; 1975; 51 Suppl 1(593):144-8. PubMed ID: 768955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenfluramine in management of obese diabetics.
    Misra NP; Bhambal SA; Yesikar SS; Bellani RK
    J Assoc Physicians India; 1980 Sep; 28(9):287-95. PubMed ID: 7007309
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenformin compared with fenfluramine in the treatment of obese diabetic patients.
    Kesson CM; Ireland JT
    Practitioner; 1976 May; 216(1295):577-80. PubMed ID: 781656
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypoglycemic action of fenfluramine in obese diabetics].
    De Sereday MS; Efron HR; De Compte DV; Raffo del Campo MA
    Prensa Med Argent; 1971 Jul; 58(20):1030-3. PubMed ID: 4938286
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of new formulation of fenfluramine in the management of the obese, diabetic African.
    Wilton D
    Postgrad Med J; 1975; 51 Suppl 1():138-9. PubMed ID: 1219673
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms for the effects of benfluorex on the obese-diabetic-dyslipidemic syndrome.
    Brindley DN
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():51S-56S. PubMed ID: 8299490
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative unresponsiveness of obese diabetic compared to obese non-diabetic subjects to the weight-reducing effect of fenfluramine.
    Otim MA
    East Afr Med J; 1977 Feb; 54(2):91-5. PubMed ID: 885093
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral and metabolic effects of fenfluramine, 780SE, norfenfluramine and hydroxyethylnorfenfluramine--a review.
    Macrae SM
    Postgrad Med J; 1975; 51 Suppl 1():13-7. PubMed ID: 768953
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is fenfluramine suitable as a therapeutic principle in obese aged diabetics? (end)].
    Förster H; Huth K; Koch E; Tunali G
    Fortschr Med; 1979 Feb; 97(6):259-62. PubMed ID: 428867
    [No Abstract]   [Full Text] [Related]  

  • 12. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the energy and biochemical status of obese and non-obese students treated with 780SE.
    Miller DS; Evans E; Samuel P; Burland WL
    Postgrad Med J; 1975; 51 Suppl 1():117-20. PubMed ID: 1219667
    [No Abstract]   [Full Text] [Related]  

  • 15. A six month study of a carbohydrate restricted diet in the management of maturity-onset diabetes and an evaluation of fenfluramine in patients unresponsive to this diet.
    Luntz GR; Reuter CJ
    Postgrad Med J; 1975; 51 Suppl 1():133-7. PubMed ID: 1219671
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
    Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P
    Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Fenfluramine in complicated obesity.
    Wilton TD
    S Afr Med J; 1974 Jun; 48(31):1324. PubMed ID: 4846424
    [No Abstract]   [Full Text] [Related]  

  • 19. [New aspects in the management of overweight diabetics].
    Brumby KH
    Ther Ggw; 1979 Apr; 118(4):558-66. PubMed ID: 462386
    [No Abstract]   [Full Text] [Related]  

  • 20. [A multicenter open study of dexfenfluramine in Italy. The efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. The DIMOS Group].
    Enzi G
    Ter Arkh; 1997; 69(5):71-5. PubMed ID: 9235665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.